Advances in biotechnology innovation have had an enormous transformative impact on many sectors of the U.S. economy — life-saving drugs for patients of all ages, protecting plants that are key to feeding the world and industrial biotechnology applications that are leading to bio-based fuels, chemicals and products that can protect our environment.
The bioscience’s need for a stable and supportive public policy framework is vital to industry firms large and small. It is almost impossible for any state or region to ignore the need for selective incentives to either hold existing bioscience companies or attract new enterprises.